Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST09 VTP in Recurrent Prostate Cancer
NCT00312442Phase 3Terminated
- Sponsor
- Steba Biotech
- Start
- May 2006
- Primary completion
- Jul 2008
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of padoporfin in prostate cancer (PCa), sponsored by Steba Biotech. Started May 2006; status: terminated.
02
Drugs
padoporfin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00312442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312442.